Officer sold ~$3.78M of Centene Corporation
Automatic saleLoading…
Centene Corporation
CNC · NYSE · Managed Health Care
CNC · NYSE · Managed Health Care
Managed Health Care company based in St. Louis, Missouri.
In the last 90 days, no insider of Centene Corporation reported an open-market purchase and 2 open-market sales worth about $6.89M. The latest 13F reports cover the quarter ending Jun 30, 2026. Every figure links to its official SEC, House, Senate or USAspending record.
Last close, Oct 5, 2026
$64.30
Adjusted for splits and dividends
Last 12 months
+66.2%
S&P 500 +15.8% over the same dates
Market value
$31.8B
Last close × shares outstanding
Bets against the stock: 14.1M shares sold short (2.9% of shares outstanding), +5.3% vs the previous count, 3.5 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Revenue
$53.6B
+9.9% vs the same quarter a year earlier
Free cash flow, last 12 months
$8.95B
This quarter $3.42B, a year earlier $1.58B
Net cash
$8.05B
Debt $16.1B, cash $24.2B, at Jun 30, 2026
Net income, last 12 months
-$5.1B
Operating profit covers interest -8.6x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 28, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
2 sales
$6.89M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$195B
+19.4% vs the year before
Net income, fiscal 2025
-$6.67B
A loss for the year
Shares outstanding
494M
As of Jul 24, 2026
In fiscal 2025 the company spent $475M buying back its own shares. Cash actually paid, from its cash-flow statement.
Officer sold ~$3.78M of Centene Corporation
Automatic saleOfficer sold ~$3.11M of Centene Corporation
Automatic saleFrom a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Director sold ~$5.16M of Centene Corporation
Automatic saleA Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
A securities lawsuit naming the company as a defendant was filed on Jul 9, 2025 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.
Lunstrum v. Centene Corporation, 1:25-cv-05659Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). Coverage of court records is not complete, and shareholder derivative suits are not included.
Last 12 months, adjusted daily closes
Adjusted close went from $37.64 on Oct 6, 2025 to $64.30 on Oct 5, 2026 (+70.8%). Disclosed activity in the last 12 months: 0 insider purchases, 5 insider sales (5 under pre-arranged plans), 0 Congress purchases, 0 Congress sales, 1 fund report of opening or adding and 0 fund reports of trimming or selling out (13F, quarter-end snapshots).
Vanguard Capital Management
Schedule 13G: passive · filed Apr 29, 2026 · 35.9M shares
AQR Capital Management, LLC
Schedule 13G: passive · filed Feb 13, 2026 · 31.8M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Top officer leaving
“COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On August 12, 2026, Andrew Asher, Chief Financial Officer of Centene Corporation (the Company), informed the Company that he intends to retire as Chief Financial Officer effective as of December 31, 2026.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Short sale volume: 42.2% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 36.3%. FINRA daily files, to Oct 5, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.